tiprankstipranks

Kenneth Dipietro Insider Profile

4 Followers
Kenneth Dipietro, EVP HR at Biogen, holds 24.66K shares in Cerevel Therapeutics Holdings (Ticker: CERE), holds 7.18K shares in Biogen (Ticker: BIIB), holds 0.00 shares in Invivo Therapeutics Holdings (Ticker: NVIVQ).
tipranks
Kenneth Dipietro

Kenneth Dipietro
Biogen (BIIB)
EVP HR

Not Ranked
Kenneth Dipietro has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
60.67%
39.33%
A breakdown of Kenneth Dipietro's holdings

Insider Roles

Biogen
(BIIB)
EVP HR
Cerevel Therapeutics Holdings
(CERE)
CHRO
Roles that Kenneth Dipietro holds in companies

Most Profitable Insider Trade

Stock:
Cerevel Therapeutics Holdings
(CERE)
Rating:Informative Sell
Date:Dec 27, 2023 - Today
Return:+4.70%
The most profitable trade made by Kenneth Dipietro

Kenneth Dipietro's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Biogen
Mar 02, 2017
EVP HR
Uninformative Buy
935.06K
$1.61M
Cerevel Therapeutics Holdings
Dec 27, 2023
CHRO
Uninformative Buy
28.00K
$1.05M
NVIVQ
Invivo Therapeutics Holdings
$0.00
List of latest transactions for each holding click on a transaction to see Kenneth Dipietro's performance on stock

Kenneth Dipietro insider profile FAQ

What is the percentage of profitable transactions made by Kenneth Dipietro?
The percentage of profitable transactions made by Kenneth Dipietro is ―.
    What is the average return per transaction made by Kenneth Dipietro?
    The average return per transaction made by Kenneth Dipietro is ―.
      What stocks does Kenneth Dipietro hold?
      Kenneth Dipietro holds: BIIB, CERE, NVIVQ stocks.
        What was Kenneth Dipietro’s latest transaction?
        Kenneth Dipietro latest transaction was an Uninformative Buy of $28.00K.
          What was Kenneth Dipietro's most profitable transaction?
          Kenneth Dipietro’s most profitable transaction was an Informative Sell of CERE stock on December 27, 2023. The return on the trade was 4.70%.
            What is Kenneth Dipietro's role in Biogen?
            Kenneth Dipietro's role in Biogen is EVP HR.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.